ANNA HOLLAND: Open Payments
NPI 1962740126 · HARTSELLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,594 in 123 payments from 26 companies in 2025. Trend: 2023 $2,008 · 2024 $2,050 · 2025 $2,594
Food & beverage: $2,594
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $473 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $250 |
| Dexcom, Inc. | 5 | $221 |
| ABBVIE INC. | 13 | $217 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| Corcept Therapeutics | 5 | $123 |
| PFIZER INC. | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Lundbeck LLC | 5 | $101 |
| Lilly USA, LLC | 5 | $99 |
Products named: CAPLYTA, Wegovy, REXULTI, DEXCOM G7 GSS (161), Ozempic, Korlym, JARDIANCE, VRAYLAR.
Industry payments across AL — which companies pay providers there.
